Adicet Bio, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Adicet Bio, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $82.00K, a 69.29% decline year-over-year.
- Adicet Bio, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $267.00K, a 34.85% increase year-over-year.
- Adicet Bio, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $198.00K, a 12.00% decline year-over-year.
- Adicet Bio, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $225.00K, a 10.84% increase year-over-year.
- Adicet Bio, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $326.00K, a 2.69% decline from fiscal 2024.
- Adicet Bio, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $335.00K, a 12.30% decline from fiscal 2023.
- Adicet Bio, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $382.00K, a 11.57% decline from fiscal 2022.
- Adicet Bio, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $432.00K, a 234.88% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $82.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $326.00K 10-K · filed 2026-03-12 | |
| 2025-06-30 | $267.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $335.00K 10-K · filed 2026-03-12 | |
| 2024-06-30 | $198.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $382.00K 10-K · filed 2025-03-06 | |
| 2023-06-30 | $225.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $432.00K 10-K · filed 2024-03-19 | |
| 2022-06-30 | $203.00K 10-Q · filed 2022-11-08 | |
| 2021-12-31 | $129.00K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |